Before COVID, the single mother of two teenagers had few financial worries. She worked as a sales associate for a telecommunications provider, selling internet services to businesses. "I was making ...

Early in his career, Michael Allon, M.D., professor in the UAB Division of Nephrology, Department of Medicine, noticed that the prevailing wisdom concerning vascular access did not match his observed ...

WALLINGFORD, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- X9, Inc. today announced positive results from its first-in-human clinical feasibility study evaluating the X9 Ultrasound System with ...

Humacyte (HUMA) just shared new two-year results from its V007 Phase 3 study at Kidney Week 2025. The ATEV device performed better than traditional AV fistulas for hemodialysis access, particularly in ...

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA) announced Monday that its acellular tissue engineered vessel (ATEV) demonstrated superior duration of use over 24 months compared to autogenous fistula in ...

For adults undergoing hemodialysis, vascular access through an arteriovenous fistula is linked to greater patient satisfaction. “Although AVF patients reported more discomfort related to physical ...

FAIRFAX, Va., Sept. 9, 2025 /PRNewswire/ -- The Society of Interventional Radiology (SIR) published new practice guidance for the creation of percutaneous arteriovenous fistulas (pAVFs) for dialysis ...

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway. Objective: To ...